Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) 2.4 mg/2.4 mg s.c. once weekly versus tirzepatide 15 mg s.c. once weekly in participants with type 2 diabetes inadequately controlled on metformin with or without an SGLT2 inhibitor
Phase III
Mei-Yueh Lee
郭盈蘭
On-going
Endocrinology and Metabolism
Evaluating Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System by Comparing Self Blood Glucose Monitoring in Children, Adolescents and Adults with Diabetes: A Pilot Study.
Class II
Mei-Yueh Lee
郭盈蘭
On-going
Endocrinology and Metabolism
Evaluating Effectiveness of the Rightest Continuous Glucose Monitoring System by Comparing Self Blood Glucose Monitoring in Patients with Diabetes and Explore the Influence of Ascorbic Acid.
Class III
Mei-Yueh Lee
郭盈蘭
Completed
Diabetes Mellitus
Endocrinology and Metabolism
A Multicenter, Randomized, single-blinded, Parallel-group, placebo-controlled Phase II Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally-administered TTP273 Tablets in Adult Patients with Type 2 Diabetes Mellitus (T2DM)
Phase II
Mei-Yueh Lee
Completed
Endocrinology and Metabolism
Evaluation of the bone density and body composition of thyroid cancer patients taking thyroxine and it’s response to osteoporosis treatment
--
Mei-Yueh Lee
楊璦甄
Completed
Endocrinology and Metabolism
Analysis of bone density, body composition and physiological assessment factors in early-stage elderly patients with type 2 diabetes
--
Mei-Yueh Lee
楊璦甄
Completed
Diabetes Mellitus
Endocrinology and Metabolism
A pivotal study to evaluate the safety and effectiveness of Rightest Continuous Glucose Monitoring System for blood glucose management in person with diabetes mellitus
